In summary, our functional experiments demonstrated that inhibiting LIMK1 reduces cellular senescence and inhibits tumor cell proliferation, while reducing WRN has the opposite effect, indicating their potential as therapeutic targets. The gene discussed is WRN; the disease is neoplasm.